This study examines the spatial distribution of consumption competitiveness and carrying capacity across regions, exploring their interrelationship and implications for sustainable regional development. An evaluation index system is constructed for both consumption competitiveness and carrying capacity using a range of economic, social, and environmental indicators. We apply this framework to regional data in China and analyze the resultant spatial patterns. The findings reveal significant regional disparities: areas with strong consumption competitiveness are often concentrated in economically developed regions, while high carrying capacity is notable in less populated or resource-rich areas. Notably, a mismatch emerges in some regions—high consumer demand is not always supported by adequate carrying capacity, and vice versa. These disparities highlight potential sustainability challenges and opportunities. In the discussion, we address reasons behind the spatial mismatch and propose policy implications to better align consumer market growth with regional resource and environmental capacity. The paper concludes that integrating consumption-driven growth strategies with carrying capacity considerations is essential for balanced and sustainable regional development.

The Ecuadorian electricity sector encompasses generation, transmission, distribution and sales. Since the change of the Constitution in Ecuador in 2008, the sector has opted to employ a centralized model. The present research aims to measure the efficiency level of the Ecuadorian electricity sector during the period 2012–2021, using a DEA-NETWORK methodology, which allows examining and integrating each of the phases defined above through intermediate inputs, which are inputs in subsequent phases and outputs of some other phases. These intermediate inputs are essential for analyzing efficiency from a global view of the system. For research purposes, the Ecuadorian electricity sector was divided into 9 planning zones. The results revealed that the efficiency of zones 6 and 8 had the greatest impact on the overall efficiency of the Ecuadorian electricity sector during the period 2012–2015. On the other hand, the distribution phase is the most efficient with an index of 0.9605, followed by sales with an index of 0.6251. It is also concluded that the most inefficient phases are generation and transmission, thus verifying the problems caused by the use of a centralized model.

The fast-growing field of nanotheranostics is revolutionizing cancer treatment by allowing for precise diagnosis and targeted therapy at the cellular and molecular levels. These nanoscale platforms provide considerable benefits in oncology, including improved disease and therapy specificity, lower systemic toxicity, and real-time monitoring of therapeutic outcomes. However, nanoparticles' complicated interactions with biological systems, notably the immune system, present significant obstacles for clinical translation. While certain nanoparticles can elicit favorable anti-tumor immune responses, others cause immunotoxicity, including complement activation-related pseudoallergy (CARPA), cytokine storms, chronic inflammation, and organ damage. Traditional toxicity evaluation approaches are frequently time-consuming, expensive, and insufficient to capture these intricate nanoparticle-biological interactions. Artificial intelligence (AI) and machine learning (ML) have emerged as transformational solutions to these problems. This paper summarizes current achievements in nanotheranostics for cancer, delves into the causes of nanoparticle-induced immunotoxicity, and demonstrates how AI/ML may help anticipate and create safer nanoparticles. Integrating AI/ML with modern computational approaches allows for the detection of potentially dangerous nanoparticle qualities, guides the optimization of physicochemical features, and speeds up the development of immune-compatible nanotheranostics suited to individual patients. The combination of nanotechnology with AI/ML has the potential to completely realize the therapeutic promise of nanotheranostics while assuring patient safety in the age of precision medicine.